NDA leaders convened at BJP headquarters to strategize for the ongoing assembly elections in Maharashtra and Jharkhand, as well as upcoming electoral challenges... IndiaTimes
A Delhi court extended AAP MLA Amanatullah Khan's judicial custody till November 16 in the Delhi Waqf Board money laundering case. The Enforcement Directorate.. IndiaTimes
The Supreme Court emphasized the need to manage pollution caused by firecrackers, cautioning that unchecked pollution contributes to disorder and health risks. DNA
In areas like Punjabi Bagh, Wazirpur, Ashok Vihar, Bawana, Jahangirpuri, Mundka, Rohini, Moti Bagh, and Patparganj, the air quality worsened with AQI hit the.. DNA
A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccine’s potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research.
#IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity
~HT.97~PR.152~
World Projected to Spend $157 Billion
on COVID-19 Vaccines by 2025.
On Thursday, IQVIA Holdings Inc released a report
detailing global spending on COVID-19 vaccines. .
According to the U.S. health..
Credit: Wibbitz Top Stories Duration: 01:04Published
During a press conference in Delhi over COVID situation in India, AIIMS Delhi Director Dr Randeep Guleria on April 30 advised people on when to discontinue home isolation. "When to discontinue home..
Amid increasing demand for Remdesivir injections across the country in wake of the devastating second wave of COVID-19, Delhi AIIMS Director Dr Randeep Guleria on April 30 advised people not to take..